Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.79 |
| ▸ | CTSS | P25774 | 3/20 | 0.70 |
| ▸ | CTSK | P43235 | 2/20 | 0.70 |
| ▸ | CTSL | P07711 | 1/20 | 0.70 |
| ▸ | CTSB | P07858 | 1/20 | 0.70 |
| ▸ | PPARA | Q07869 | 5/20 | 0.64 |
| ▸ | PPARG | P37231 | 4/20 | 0.64 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.62 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.62 |
| ▸ | APP | P05067 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 2/20 | 0.61 |
| ▸ | AKT1 | P31749 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | PPARD | Q03181 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL795685 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL27909397 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL21473784 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL67020 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL66220 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL29707278 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB | |
| Water SCHEMBL15362012 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB | |
| Water SCHEMBL15362013 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL26654474 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL26654472 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010833-A | Method for catalyzing tension ring heteroaryl by iron | 南京师范大学 | 2026-05-12 | — | — | CN | claimed |
| CN-118878622-B | Green chemical synthesis method of illegal stand | 中肽生化有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-119818387-A | Application and synthesis method of cyclic peptide | 上海中翊日化有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119798139-A | Method for synthesizing phenolic compound by iron-catalyzed hydroxylation reaction of aromatic compound | 南京师范大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119798062-A | Method for catalyzing quinone hydroxylation reaction of alkene by iron | 南京师范大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119798083-A | Iron-catalyzed aromatic compound carbon-hydrogen bond hydroxylation nitration method | 南京师范大学 | 2025-04-11 | — | — | CN | claimed |
| US-20250019367-A1 | Methods for Separation of Enantiomers | Mirati Therapeutics, Inc. | 2025-01-16 | — | — | US | claimed |
| CN-116199572-B | Method for alpha-bromination of iron-catalyzed ketone | 南京师范大学 | 2025-01-14 | — | — | CN | claimed |
| CN-115925544-B | Method for ring-opening acrylation of tertiary alcohol through iron catalytic oxidation | 南京师范大学 | 2025-01-14 | — | — | CN | claimed |
| CN-119264009-A | Photoisomerization chiral hydrogel material and preparation method and application thereof | 河南大学 | 2025-01-07 | — | — | CN | claimed |
| US-20140135509-A1 | Process for the Preparation of Benzyl [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and Intermediates in the Process | ASTRAZENECA AB (SE) | 2014-05-15 | — | — | US | claimed |
| EP-2707363-A1 | A PROCESS FOR THE PREPARATION OF BENZYL [(3AS,4R,6S,6AR)-6-HYDROXY-2,2- DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA[D][1,3]DIOXOL]-4-YL]CARBAMATE AND INTERMEDIATES IN THE PROCESS | AstraZeneca AB (SE) | 2014-03-19 | — | — | EP | claimed |
| CN-103534245-A | A process for the preparation of benzyl [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and intermediates in the process | ASTRAZENECA AB | 2014-01-22 | — | — | CN | claimed |
| WO-2012158099-A1 | A PROCESS FOR THE PREPARATION OF BENZYL [(3AS,4R,6S,6AR)-6-HYDROXY-2,2- DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA[D][1,3]DIOXOL]-4-YL]CARBAMATE AND INTERMEDIATES IN THE PROCESS | ASTRAZENECA AB (SE) | 2012-11-22 | — | — | WO | claimed |
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2012-02-16 | — | — | US | claimed |
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | claimed |
| CN-101274958-A | Bioactive peptide, preparation thereof and application thereof | OCEAN UNIV CHINA (CN) | 2008-10-01 | — | — | CN | claimed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| CN-1116424-A | Process for producing 3-amino-2-hydroxy-1-propanol derivative | KANEKA CORP (JP) | 1996-02-07 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250019367-A1 | Methods for Separation of Enantiomers | PAH, NPEPPS, DNPEP | ACE 393/4885CTSS 971/4885CTSK 734/4885 |
| US-20140135509-A1 | Process for the Preparation of Benzyl [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and Intermediates in the Process | CYP4X1, CYP4B1, CBR3 | ACE 2967/4885CTSS 824/4885CTSK 1546/4885 |
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | ACKR3, KIT, C3AR1 | ACE 140/4885CTSS 1371/4885CTSK 1088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.